
Analyst Coverage Updates
Analyst Ratings-USA
June 26th, 2025
Analysts collectively signal a bullish market with growth opportunities, showing confidence in strong corporate earnings, growth potential, and improving economic conditions, while recommending caution in select areas. This outlook suggests investors might consider being invested but remain watchful for risks or volatility.
Analyst Coverage Updates:
Company Name
Symbol
Action
Investment Bank
Analyst Rating
Target Price
A. O. Smith Corporation AOS Target Update UBS Hold $74.00
Abercrombie Fitch ANF Target Update UBS Buy $130.00
Abivax SA Sponsored ADR ABVX Target Update LifeSci Capital Buy $45.00
Acuity Brands AYI Target Update TD Cowen Buy $330.00
Advance Auto Parts AAP Target Update Evercore ISI Hold $52.00
AFLAC AFL Target Update TD Cowen Hold $100.00
Aldeyra Therapeutics ALDX Target Update JonesTrading Buy $6.00
Alphabet Class A GOOGL Target Update RBC Capital Buy $200.00
Altimmune ALT Target Update B.Riley Financial Buy $20.00
Altimmune ALT Target Update H.C. Wainwright Buy $12.00
Amarin AMRN Target Update Goldman Sachs Sell $12.00
Amazon AMZN Target Update Exane BNP Paribas Buy $254.00
Amazon AMZN Target Update Bank of America Securities Buy $248.00
Ambarella AMBA Target Update Rosenblatt Securities Buy $95.00
Ambarella AMBA Target Update Stifel Nicolaus Buy $80.00
Arcturus Therapeutics ARCT Target Update Scotiabank Buy $32.00
Array Technologies ARRY Target Update Goldman Sachs Buy $11.00
ArriVent BioPharma, Inc. AVBP Target Update Clear Street Buy $32.00
aTyr Pharma ATYR Target Update Leerink Partners Buy $16.00
Autoliv ALV Target Update Morgan Stanley Hold $117.60
Baker Hughes Company BKR Target Update Jefferies Buy $52.00
Beam Therapeutics BEAM Target Update J.P. Morgan Buy $48.00
Bill.com Holdings BILL Target Update KBW Hold $54.00
Biogen BIIB Target Update RBC Capital Buy $213.00
Blackstone Group BX Target Update TD Cowen Buy $196
Capricor Therapeutics CAPR Target Update JonesTrading Buy $29
Carnival CCL Target Update J.P. Morgan Buy $34.00
Carnival CCL Target Update Mizuho Securities Buy $35.00
Carnival CCL Target Update Goldman Sachs Buy $33.00
Cheniere Energy LNG Target Update Bank of America Securities Buy $271.00
Cheniere Energy Partners CQP Target Update Bank of America Securities Sell $53.00
Chevron CVX Target Update RBC Capital Buy $175.00
Cibus CBUS Target Update Canaccord Genuity Buy $15.00
Circle Internet Group, Inc. Class A CRCL Target Update US Tiger Securities Hold $200.00
Citigroup C Target Update Truist Financial Buy $84
Cogent Biosciences COGT Target Update Piper Sandler Buy $24.00
Coinbase Global COIN Target Update Citizens JMP Buy $400.00
Comcast CMCSA Target Update Benchmark Co. Buy $48.00
Commercial Metals Company CMC Target Update UBS Hold $48.00
Constellation Brands STZ Target Update Needham Buy $195
Constellation Brands STZ Target Update UBS Buy $195.00
Corebridge Financial, Inc. CRBG Target Update Evercore ISI Buy $39.00
Corvus Pharmaceuticals CRVS Target Update Mizuho Securities Buy $11.00
Crescent Biopharma CBIO Target Update Stifel Nicolaus Buy $28.00
Crispr Therapeutics AG CRSP Target Update Goldman Sachs Hold $47.00
CSX CSX Target Update BMO Capital Buy $36.00
Darden Restaurants DRI Target Update Stifel Nicolaus Buy $245.00
Delcath Systems DCTH Target Update Canaccord Genuity Buy $21
Dexcom DXCM Target Update Oppenheimer Buy $95.00
DHI Group DHX Target Update Barrington Buy $11.50
Dollar Tree DLTR Target Update Evercore ISI Hold $94.00
DTE Energy DTE Target Update UBS Buy $148.00
Duolingo DUOL Target Update D.A. Davidson Buy $500.00
Eli Lilly & Co LLY Target Update TD Cowen Buy $960.00
EMCOR Group EME Target Update Robert W. Baird Buy $560.00
EPR Properties EPR Target Update Stifel Nicolaus Buy $65.00
Equinix EQIX Target Update Citi Buy $990.00
Etsy ETSY Target Update Truist Financial Buy $60.00
Eversource Energy ES Target Update Mizuho Securities Buy $72.00
Exelixis EXEL Target Update Jefferies Buy $50.00
Exxon Mobil XOM Target Update RBC Capital Hold $105.00
Factset Research FDS Target Update UBS Hold $480.00
FedEx FDX Target Update Susquehanna Buy $295.00
FedEx FDX Target Update Raymond James Buy $260.00
FedEx FDX Target Update Truist Financial Buy $275.00
Flowco Holdings Inc Class A FLOC Target Update Jefferies Buy $32.00
Flowserve FLS Target Update Jefferies Buy $65.00
Franklin Covey Company FC Target Update Barrington Buy $35.00
Gain Therapeutics GANX Target Update Scotiabank Buy $12.00
General Dynamics GD Target Update TD Cowen Buy $300.00
General Mills GIS Target Update Bernstein Hold $55.00
General Mills GIS Target Update Evercore ISI Hold $54.00
Gitlab GTLB Target Update Goldman Sachs Hold $50.00
Glacier Bancorp GBCI Target Update Piper Sandler Hold $47
GMS GMS Target Update Truist Financial Hold $105.00
Gold Fields GFI Target Update RBC Capital Buy $32.00
Guidewire GWRE Target Update J.P. Morgan Buy $288.00
Gyre Therapeutics GYRE Target Update Stifel Nicolaus Buy $28.00
H.B. Fuller Company FUL Target Update Citi Hold $62.00
Health In Tech, Inc. Class A HIT Target Update Maxim Group Buy $2.50
Heidrick & Struggles HSII Target Update Truist Financial Hold $46.00
Helmerich & Payne HP Target Update RBC Capital Hold $23.00
Hess HES Target Update UBS Buy $173.00
Hub Group HUBG Target Update BMO Capital Hold $38.00
Humana HUM Target Update Truist Financial Hold $280.00
I-MAB IMAB Target Update H.C. Wainwright Buy $7.00
Idexx Laboratories IDXX Target Update Leerink Partners Buy $580.00
Immuneering IMRX Target Update Jefferies Hold $3.50
International Paper Co IP Target Update Truist Financial Buy $59.00
Intuit INTU Target Update Citi Buy $789.00
Jack In The Box JACK Target Update Stifel Nicolaus Hold $20.00
JB Hunt JBHT Target Update BMO Capital Buy $172.00
KalVista Pharmaceuticals KALV Target Update Stifel Nicolaus Buy $39.00
KalVista Pharmaceuticals KALV Target Update JonesTrading Buy $30.00
Kennametal KMT Target Update Loop Capital Markets Hold $24.00
Keurig Dr Pepper KDP Target Update UBS Buy $42.00
Korn Ferry KFY Target Update Truist Financial Buy $88.00
Kratos Defense KTOS Target Update Truist Financial Buy $52.00
Krispy Kreme DNUT Target Update Truist Financial Hold $5.00
Kroger Company KR Target Update Northcoast Research Buy $80.00
Krystal Biotech KRYS Target Update TD Cowen Buy $202.00
Liberty Media Liberty Formula One FWONK Target Update Susquehanna Buy $121.00
Louisiana-Pacific LPX Target Update D.A. Davidson Buy $117.00
Lucky Strike Entertainment LUCK Target Update Stifel Nicolaus Buy $12.00
Lyft LYFT Target Update Canaccord Genuity Hold $14.00
McCormick & Company MKC Target Update Jefferies Buy $90.00
McCormick & Company MKC Target Update UBS Hold $83.00
Meta Platforms META Target Update RBC Capital Buy $740.00
Microchip MCHP Target Update Truist Financial Hold $64.00
Micron MU Target Update CFRA Buy $155.00
Microsoft MSFT Target Update Wedbush Buy $600.00
Molecular Partners MOLN Target Update LifeSci Capital Buy $12.00
Napco Security Technologies NSSC Target Update D.A. Davidson Buy $33.00
National Cinemedia NCMI Target Update Benchmark Co. Buy $7
Nektar Therapeutics NKTR Target Update H.C. Wainwright Buy $120.00
Nektar Therapeutics NKTR Target Update BTIG Buy $100.00
Nektar Therapeutics NKTR Target Update Piper Sandler Buy $105.00
NeuroPace NPCE Target Update Leerink Partners Buy $17.00
Newmont Mining NEM Target Update National Bank Hold $100.00
Nexstar Media Group NXST Target Update Guggenheim Buy $220.00
Nextdoor Holdings KIND Target Update B.Riley Financial Hold $2.00
Nike NKE Target Update RBC Capital Hold $65.00
Norfolk Southern NSC Target Update BMO Capital Hold $270.00
Nurix Therapeutics NRIX Target Update Oppenheimer Buy $32.00
Nuvalent NUVL Target Update UBS Buy $114.00
Nuvalent NUVL Target Update Robert W. Baird Buy $112.00
Nuvation Bio NUVB Target Update Citizens JMP Buy $6.00
Nvidia NVDA Target Update Loop Capital Markets Buy $250
Old Dominion Freight ODFL Target Update BMO Capital Hold $172.00
OnKure Therapeutics OKUR Target Update LifeSci Capital Buy $20.00
Option Care Health OPCH Target Update UBS Buy $40.00
Packaging PKG Target Update Truist Financial Buy $239.00
Patterson-UTI PTEN Target Update RBC Capital Buy $9.00
Paychex PAYX Target Update Morgan Stanley Hold $148.00
Paylocity PCTY Target Update TD Cowen Buy $227.86
PennyMac Financial PFSI Target Update BTIG Buy $135.00
Phibro Animal Health PAHC Target Update Morgan Stanley Hold $26.00
Plymouth Industrial Reit PLYM Target Update Colliers Securities Buy $19.50
Postal Realty PSTL Target Update Stifel Nicolaus Buy $18.25
Real Brokerage REAX Target Update B.Riley Financial Buy $7
Reddit Inc Class A RDDT Target Update RBC Capital Hold $125.00
Revolution Medicines RVMD Target Update Needham Buy $57.00
RH RH Target Update Goldman Sachs Sell $179.00
Rivian Automotive RIVN Target Update Mizuho Securities Hold $13.00
RXO, Inc. RXO Target Update TD Cowen Hold $15.00
Samsara IOT Target Update Truist Financial Hold $42.00
Samsara IOT Target Update Loop Capital Markets Buy $50.00
Samsara IOT Target Update TD Cowen Buy $51.00
Samsara IOT Target Update Piper Sandler Buy $53.00
Samsara IOT Target Update RBC Capital Buy $54.00
Sangamo Biosciences SGMO Target Update H.C. Wainwright Buy $10.00
ServiceNow NOW Target Update D.A. Davidson Buy 1,150.00
Sirius XM Holdings SIRI Target Update J.P. Morgan Sell $20.00
SL Green Realty SLG Target Update Piper Sandler Buy $72.00
Spotify SPOT Target Update Bank of America Securities Buy $900.00
Sun Communities SUI Target Update Deutsche Bank Hold $135.00
Surgery Partners SGRY Target Update UBS Buy $34.00
Talos Energy TALO Target Update Roth MKM Buy $11.00
TD SYNNEX Corporation SNX Target Update Barclays Hold $140.00
TD SYNNEX Corporation SNX Target Update UBS Buy $154.00
Telecom Argentina TEO Target Update J.P. Morgan Hold $11.00
Tesla TSLA Target Update RBC Capital Buy $307.00
Texas Instruments TXN Target Update TD Cowen Hold $200.00
The Estée Lauder Companies EL Target Update HSBC Buy $69.67
Theravance Biopharma TBPH Target Update BTIG Buy $25.00
Theravance Biopharma TBPH Target Update JonesTrading Buy $24.00
TMC the metals company TMC Target Update Wedbush Buy $11.00
Uber Technologies UBER Target Update Canaccord Genuity Hold $84.00
UMB Financial UMBF Target Update Piper Sandler Buy $135.00
Union Pacific UNP Target Update BMO Capital Buy $270.00
UnitedHealth UNH Target Update UBS Buy $385.00
Venture Global, Inc. VG Target Update Bank of America Securities Buy $18.50
Veradigm MDRX Target Update TD Cowen Buy $8.00
Verastem VSTM Target Update RBC Capital Buy $12.00
Verizon VZ Target Update Exane BNP Paribas Buy $51.00
Verve Therapeutics VERV Target Update BMO Capital Hold $13.50
VNET Group, Inc. Sponsored ADR VNET Target Update Bank of America Securities Buy $11.30
Vor Biopharma VOR Target Update Robert W. Baird Hold $1.00
Vor Biopharma VOR Target Update Stifel Nicolaus Hold $0.30
VSE VSEC Target Update Jefferies Buy $157.00
Walgreens Boots Alliance WBA Target Update Evercore ISI Hold $11.45
Waste Management WM Target Update Oppenheimer Buy $255.00
Watsco WSO Target Update UBS Hold $450.00
Wells Fargo WFC Target Update Morgan Stanley Buy $87.00
Westlake Corporation WLK Target Update Alembic Global Buy $100.00
Winnebago Industries WGO Target Update Roth MKM Hold $37.00
Workiva WK Target Update Robert W. Baird Buy $105.00
XPO XPO Target Update TD Cowen Buy $133.00
XPO XPO Target Update BMO Capital Buy $146.00
Zimmer Biomet Holdings ZBH Target Update BTIG Buy $117
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
18 minutes ago
- Globe and Mail
The Zacks Analyst Blog Highlights Apple, Netflix and Disney
For Immediate Release Chicago, IL – June 27, 2025 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple AAPL, Netflix NFLX and Disney DIS. Here are highlights from Thursday's Analyst Blog: Apple Continues to Expand Services Business: What's the Path Ahead? Apple is continuously upgrading features of its Services offerings that revolve around the flagship device, iPhone. The company now has more than 1 billion paid subscribers across its Services portfolio, more than double what it had four years ago. In the fiscal second quarter, Services revenues grew 11.6% year over year to $26.65 billion. Infusion of Apple Intelligence into Services offerings like Apple Wallet and Apple Music is expected to drive top-line growth. At its latest annual Worldwide Developers Conference, Apple announced expansion to the Services business with AutoMix and Lyrics Translation features in Apple Music. Sing will allow users to transform their iPhones into a handheld microphone for Apple TV, while preferred routes and visited places in Apple Maps make navigation easier for users. Apple Intelligence is now getting added to Apple Wallet, and users can make purchases with Apple Pay. Powered by Apple Intelligence, Apple Wallet can now automatically identify, summarize and display order tracking details from emails sent from merchants or delivery carriers. Meanwhile, Apple Pay expands the ability to pay with rewards and installments to in-store purchases for added flexibility and choice. The company also introduced an update to Apple Maps that helps users search and discover top-ranked restaurants, hotels, golf courses and more, with the addition of rankings and insights from expert sources. Per our model, Apple's Services revenues are expected to see a CAGR of 15.6% between 2024 and 2027. Apple Faces Stiff Competition Netflix and Disney are major competitors in the Services space. Netflix is benefiting from its growing subscriber base, thanks to a robust localized and foreign-language content portfolio and healthy engagement levels with about two hours of viewing per member per day, indicating strong member retention. Netflix has set an ambitious target to double its revenues by 2030, supported by a diversified content strategy, including international programming, live events and gaming initiatives. Disney, on the other hand, has built up a massive global audience for its ad-supported streaming content. It has an estimated 157 million active users worldwide, 112 million of whom are of Disney's streaming platforms in the United States. Disney is benefiting from strength in Domestic Parks & Experiences revenues driven by growth at domestic parks, Disney Vacation Club and Disney Cruise Line. AAPL's Share Price Performance, Valuation and Estimates Apple shares have dropped 19.5% year to date (YTD), underperforming the broader Zacks Computer & Technology sector's return of 4.5%. Apple stock is trading at a premium, with a forward 12-month Price/Sales of 7.25X compared with the industry's 6.75X. AAPL has a Value Score of D. The Zacks Consensus Estimate for third-quarter fiscal 2025 earnings is pegged at $1.41 per share, unchanged over the past 30 days, indicating 0.71% year-over-year growth. Apple Inc. price-consensus-chart | Apple Inc. Quote The consensus mark for fiscal 2025 earnings is pegged at $7.11 per share, unchanged over the past 30 days, suggesting 5.33% year-over-year growth. Apple currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Why Haven't You Looked at Zacks' Top Stocks? Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year. Today you can access their live picks without cost or obligation. See Stocks Free >> Zacks Investment Research 800-767-3771 ext. 9339 support@ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren't winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%. See Our Top Stock to Double (Plus 4 Runners Up) >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Apple Inc. (AAPL): Free Stock Analysis Report Netflix, Inc. (NFLX): Free Stock Analysis Report The Walt Disney Company (DIS): Free Stock Analysis Report

CTV News
30 minutes ago
- CTV News
When will the Eglinton Crosstown LRT open? Place your bets
"Out of Service" signs are shown on the Eglinton Crosstown LRT in Toronto on Friday, May 5, 2023. Nearly 15 years after construction began, there's a possibility the long-awaited Eglinton Crosstown LRT will open this coming September. If you'd like to place your bets on that, you actually can. Online sportsbook FanDuel has a novelty betting offer on when the Eglinton LRT will be open. 'At FanDuel, our team of dedicated Canadian Traders are on the ground building novelty markets that touch on the most topical storylines across sports, entertainment, local news and pop culture,' the FanDuel Canada Trading Team told CP24 in a statement. 'Our goal is to engage in the conversations our customers are already having, offering odds on the moments that resonate.' The site has been taking wagers for a month now and following last week's announcement from Metrolinx about the current timeline for the Crosstown LRTs opening, it has seen a surge of activity. 'We have seen increasing interest in this market with 35 per cent of all bets being placed this week,' FanDuel Canada said. The top two most popular opening timelines receiving bets are 'On or after November 1st' and 'Before or on August 31st.' If correct, bettors will earn +550 for the former or +1100 for the later. The favourite however—at +195—is for the LRT to launch between Sept. 16 and Sept. 20 There are three other dates available to wager on as well. LRT bets Online sportsbook FanDuel has a novelty betting offer on when the Eglinton Crosstown LRT will be open. 'At FanDuel, we are committed to promoting responsible gaming, ensuring that our customers can enjoy these unique betting opportunities with responsible play in mind. That is why our novelty markets, including the Eglinton LRT market, carry low bet limit restrictions.' Construction on the Crosstown began in 2011 and the nearly-$13 billion line was originally expected to be complete by 2020.

Globe and Mail
an hour ago
- Globe and Mail
China eases restrictions on rare earth minerals to U.S.
China will review and approve exports of certain rare earth materials to the United States, the country's Ministry of Commerce said Friday, in exchange for Washington lifting 'a series of restrictive measures against China.' Rare earths have been a major sticking point in ongoing trade negotiations between the U.S. and China, ever since Beijing choked off the global supply of the critical minerals, vital for the production of modern automobiles, semiconductors, smartphones and military equipment. Following high-level talks in London this month, U.S. President Donald Trump said Beijing would supply rare earths and magnets, but companies had complained they were still struggling to get exports approved, often waiting weeks only to be turned down. U.S., China reach trade truce after two days of talks, Trump says On Thursday, U.S. officials indicated these problems were in the process of being ironed out, with Commerce Secretary Howard Lutnick telling Bloomberg that 'they're going to deliver rare earths to us,' after which Washington would 'take down our countermeasures.' Mr. Trump said a deal had been signed to 'open up China' on Wednesday, but did not go into details. Speaking to reporters on background, a White House official said the administration and China had agreed to an additional framework to implement their earlier trade agreement, and were working on expediting rare earth shipments to the U.S. In a statement, the Chinese Ministry of Commerce said that following a June 5 call between Mr. Trump and Chinese leader Xi Jinping, 'the teams maintained close communication' and had recently confirmed further details of a new framework. 'China will review and approve export applications for controlled items in accordance with the law,' the statement said. 'The U.S. will correspondingly lift a series of restrictive measures against China. Opinion: We have to do business with China – get over it It added it was 'hoped that the U.S. will work with China to follow through on the important consensus and requirements from the June 5 call, further leverage the China-U.S. economic and trade consultation mechanism, enhance mutual understanding, reduce misunderstandings, strengthen cooperation, and jointly promote the healthy, stable, and sustainable development of China-U.S. economic and trade relations.' While rare earths are found in a number of countries around the world, including in Canada, China holds a near-monopoly when it comes to processing the materials, producing upwards of 70 per cent of all refined critical minerals, according to the International Energy Agency. Beijing has used its leverage to great effect against the U.S. and other trade partners, few of whom export anything of equal importance to China. As U.S. trade deal deadline looms, Ottawa begins to temper expectations But the strategy is a risky one, as it has led to complaints against China at the World Trade Organization, and bolstered calls by many policymakers in the West to break dependency on Chinese rare earths by friend-shoring processing or finding alternative materials for cutting edge technologies. As well as easing restrictions on exports to the U.S., China also this week began issuing new licenses to European firms caught up in the fallout of Mr. Trump's trade war against Beijing, after weeks of lobbying by Brussels, according to the South China Morning Post. Eva Valle Lagares, the European Commission's head of trade for China, said Thursday that it was 'unclear' whether Beijing had 'intentionally hit' E.U. firms, or whether the restrictions were an unintended result of tensions with Washington. 'In reality, it is probably a mix of everything. We are looking for a far more structural and reliable long-term solution,' Ms. Valle Lagares said. 'If we ever needed a business case for de-risking, China is giving us it right now.' With files from Alexandra Li in Beijing